InsidersTradesSigma
Follow the BELITE BIO, INC stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €6.8bn. The latest transaction was filed on 14 August 2026 (Cession). Among the most active insiders: MATA NATHAN L.. Every trade is openly available.
107
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€4m
105 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate BELITE BIO, INC Strong Buy (bullish), based on 8 analysts. Average price target: US$214.00.
40Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 14 August 2026
Declarations107 total
142 shares@ US$180.000.0004% mcap1.5% of flowAmerican depositary shareSEC:0001193125-26-350217:0
223 shares@ US$180.570.0006% mcap2.3% of flowAmerican depositary shareSEC:0001193125-26-350217:1
144 shares@ US$180.000.0004% mcap2.2% of flowAmerican depositary shareSEC:0001193125-26-350218:0
223 shares@ US$180.570.0006% mcap3.4% of flowAmerican depositary shareSEC:0001193125-26-350218:1
96 sharesAmerican depositary shareSEC:0001193125-26-276615:0
3,748 sharesAmerican depositary shareSEC:0001193125-26-276615:1
4,861 sharesAmerican depositary shareSEC:0001193125-26-276615:2
1,199 sharesAmerican depositary shareSEC:0001193125-26-276615:3
96 sharesAmerican depositary shareSEC:0001193125-26-276615:4
2,054 sharesAmerican depositary shareSEC:0001193125-26-273321:0
784 sharesAmerican depositary shareSEC:0001193125-26-273321:1
3,140 sharesAmerican depositary shareSEC:0001193125-26-273321:2
540 sharesAmerican depositary shareSEC:0001193125-26-273321:3
100 sharesAmerican depositary shareSEC:0001193125-26-273321:4
450 sharesAmerican depositary shareSEC:0001193125-26-273321:5
1,897 sharesAmerican depositary shareSEC:0001193125-26-273321:6
1,035 sharesAmerican depositary shareSEC:0001193125-26-273321:7
32 shares@ US$153.4951.0% of flowAmerican depositary shareSEC:0001193125-26-206456:0
236 shares@ US$154.23757.6% of flowAmerican depositary shareSEC:0001193125-26-206456:1
325 shares@ US$155.20610.5% of flowAmerican depositary shareSEC:0001193125-26-206456:2
235 shares@ US$156.56777.7% of flowAmerican depositary shareSEC:0001193125-26-206456:3
172 shares@ US$157.49045.6% of flowAmerican depositary shareSEC:0001193125-26-206456:4
42 shares@ US$155.67670.0001% mcap0.8% of flowAmerican depositary shareSEC:0001193125-26-201466:0
517 shares@ US$156.58660.0013% mcap10.2% of flowAmerican depositary shareSEC:0001193125-26-201466:1
340 shares@ US$157.37170.0008% mcap6.7% of flowAmerican depositary shareSEC:0001193125-26-201466:2
25 of 107 declarations
关于 BELITE BIO, INC
BELITE BIO, INC 是一家在XNAS上市的公司，专注于开发代谢疾病和眼部疾病的治疗方法。该公司强调生物技术领域的创新。